CMS proposes change in the drug payment amount under Medicare Part B


(Reuters) – The Centers for Medicare & Medicaid Services on Thursday proposed a change in the payment amount for new drugs under its Part B program, amid the Trump administration’s attempts to tackle escalating prices of drugs.

FILE PHOTO: A customer waits at the counter of a CVS Pharmacy store in Pasadena, U.S., May 2, 2016. REUTERS/Mario Anzuoni/File Photo

Medicare Part B covers medicines patients receive in a doctor’s office, such as infusions, CMS said.

The move from the agency comes in the same week U.S. President Donald Trump called Pfizer Chief Executive Ian Read to say the…



Read More Here

Be the first to comment on "CMS proposes change in the drug payment amount under Medicare Part B"

Leave a comment

Your email address will not be published.


*